Oculis Holding AG (NASDAQ: OCSAW)
$1.84
-0.0700 ( -3.66% ) 3.7K
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
Market Data
Open
$1.84
Previous close
$1.91
Volume
3.7K
Market cap
$109.05M
Day range
$1.85 - $2.16
52 week range
$0.76 - $2.98
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 36 | Jun 10, 2024 |
6-k | Quarterly Reports | 4 | May 31, 2024 |
6-k | Quarterly Reports | 3 | May 08, 2024 |
6-k | Quarterly Reports | 6 | May 08, 2024 |
6-k | Quarterly Reports | 37 | Apr 29, 2024 |
6-k | Quarterly Reports | 3 | Apr 22, 2024 |
6-k | Quarterly Reports | 6 | Apr 11, 2024 |
20-f | Annual reports | 144 | Mar 19, 2024 |
6-k | Quarterly Reports | 16 | Mar 19, 2024 |
6-k | Quarterly Reports | 114 | Feb 28, 2024 |